These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 19156239)

  • 1. Clinical experience with the TandemHeart percutaneous ventricular assist device as a bridge to cardiac transplantation.
    Bruckner BA; Jacob LP; Gregoric ID; Loyalka P; Kar B; Cohn WE; La Francesca S; Radovancevic B; Frazier OH
    Tex Heart Inst J; 2008; 35(4):447-50. PubMed ID: 19156239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The TandemHeart as a bridge to a long-term axial-flow left ventricular assist device (bridge to bridge).
    Gregoric ID; Jacob LP; La Francesca S; Bruckner BA; Cohn WE; Loyalka P; Kar B; Frazier OH
    Tex Heart Inst J; 2008; 35(2):125-9. PubMed ID: 18612448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TandemHeart insertion via a femoral arterial GORE-TEX graft conduit in a high-risk patient.
    Busch J; Torre-Amione G; Noon GP; Loebe M
    Tex Heart Inst J; 2008; 35(4):462-5. PubMed ID: 19156243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience and patient outcomes associated with the TandemHeart percutaneous transseptal assist device among a heterogeneous patient population.
    Tempelhof MW; Klein L; Cotts WG; Benzuly KH; Davidson CJ; Meyers SN; McCarthy PM; Malaisrie CS; McGee EC; Beohar N
    ASAIO J; 2011; 57(4):254-61. PubMed ID: 21546824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The percutaneous ventricular assist device in severe refractory cardiogenic shock.
    Kar B; Gregoric ID; Basra SS; Idelchik GM; Loyalka P
    J Am Coll Cardiol; 2011 Feb; 57(6):688-96. PubMed ID: 20950980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the percutaneous left ventricular assist device in patients with severe refractory cardiogenic shock as a bridge to long-term left ventricular assist device implantation.
    Idelchik GM; Simpson L; Civitello AB; Loyalka P; Gregoric ID; Delgado R; Kar B
    J Heart Lung Transplant; 2008 Jan; 27(1):106-11. PubMed ID: 18187095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with the TandemHeart percutaneous ventricular assist device.
    Kar B; Adkins LE; Civitello AB; Loyalka P; Palanichamy N; Gemmato CJ; Myers TJ; Gregoric ID; Delgado RM
    Tex Heart Inst J; 2006; 33(2):111-5. PubMed ID: 16878609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of patients with cardiogenic shock treated with TandemHeart
    Smith L; Peters A; Mazimba S; Ragosta M; Taylor AM
    Catheter Cardiovasc Interv; 2018 Nov; 92(6):1173-1181. PubMed ID: 29745477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-risk percutaneous coronary intervention with the TandemHeart and Impella devices: a single-center experience.
    Schwartz BG; Ludeman DJ; Mayeda GS; Kloner RA; Economides C; Burstein S
    J Invasive Cardiol; 2011 Oct; 23(10):417-24. PubMed ID: 21972160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First use of the TandemHeart percutaneous left ventricular assist device as a short-term bridge to cardiac transplantation.
    La Francesca S; Palanichamy N; Kar B; Gregoric ID
    Tex Heart Inst J; 2006; 33(4):490-1. PubMed ID: 17215977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term mechanical circulatory support as a bridge to durable left ventricular assist device implantation in refractory cardiogenic shock: a systematic review and meta-analysis.
    den Uil CA; Akin S; Jewbali LS; Dos Reis Miranda D; Brugts JJ; Constantinescu AA; Kappetein AP; Caliskan K
    Eur J Cardiothorac Surg; 2017 Jul; 52(1):14-25. PubMed ID: 28472406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-Aortic Balloon Counterpulsation in Patients With Chronic Heart Failure and Cardiogenic Shock: Clinical Response and Predictors of Stabilization.
    Sintek MA; Gdowski M; Lindman BR; Nassif M; Lavine KJ; Novak E; Bach RG; Silvestry SC; Mann DL; Joseph SM
    J Card Fail; 2015 Nov; 21(11):868-76. PubMed ID: 26164215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful conversion of TandemHeart left ventricular assist device to right ventricular assist device after implantation of a HeartMate XVE.
    Takagaki M; Wurzer C; Wade R; Lee R; Malaisrie SC; McCarthy PM; McGee EC
    Ann Thorac Surg; 2008 Nov; 86(5):1677-9. PubMed ID: 19049776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous left ventricular assist devices for treatment of patients with cardiogenic shock.
    Windecker S
    Curr Opin Crit Care; 2007 Oct; 13(5):521-7. PubMed ID: 17762230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility study of the use of the TandemHeart percutaneous ventricular assist device for treatment of cardiogenic shock.
    Burkhoff D; O'Neill W; Brunckhorst C; Letts D; Lasorda D; Cohen HA
    Catheter Cardiovasc Interv; 2006 Aug; 68(2):211-7. PubMed ID: 16819767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Safety and Effectiveness of the Extracorporeal Continuous-Flow Ventricular Assist Device (BR16010) Use as a Bridge-to-Decision Therapy for Severe Heart Failure or Refractory Cardiogenic Shock: Study Protocol for Single-Arm Non-randomized, Uncontrolled, and Investigator-Initiated Clinical Trial.
    Fukushima N; Tatsumi E; Seguchi O; Takewa Y; Hamasaki T; Onda K; Yamamoto H; Hayashi T; Fujita T; Kobayashi J
    Cardiovasc Drugs Ther; 2018 Aug; 32(4):373-379. PubMed ID: 29948739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The TandemHeart, percutaneous transseptal left ventricular assist device: a safeguard in high-risk percutaneous coronary interventions. The six-year Rotterdam experience.
    Vranckx P; Meliga E; De Jaegere PP; Van den Ent M; Regar ES; Serruys PW
    EuroIntervention; 2008 Nov; 4(3):331-7. PubMed ID: 19110806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock.
    Burkhoff D; Cohen H; Brunckhorst C; O'Neill WW;
    Am Heart J; 2006 Sep; 152(3):469.e1-8. PubMed ID: 16923414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful use of the TandemHeart percutaneous ventricular assist device as a bridge to recovery for acute cellular rejection in a cardiac transplant patient.
    Velez-Martinez M; Rao K; Warner J; Dimaio J; Ewing G; Mishkin JD; Mammen PP; Drazner MH; Markham DW; Patel PC
    Transplant Proc; 2011 Dec; 43(10):3882-4. PubMed ID: 22172864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bridge to transplantation with the TandemHeart: bending the indications in a chronic aortic dissection patient with postcardiotomy shock.
    Reverdin S; Gregoric ID; Kar B; Loyalka P; Bieniarz MC; LeMaire SA; Coselli JS; Frazier OH
    Tex Heart Inst J; 2008; 35(3):340-1. PubMed ID: 18941602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.